Guardant’s Partnership with Janssen Bears Fruit

Guardant Health has been building up a solid liquid biopsy portfolio at a steady pace. The Redwood City, CA based-company expanded its arsenal last week when it won a nod from FDA to use the Guardant 360 CDx as a companion diagnostic for Janssen Pharmaceutical’s Rybrevant, metastatic non-small cell lung cancer (NSCLC).